Top Stories
All Sections
Finance
About
6 results for "FDA"
OpenAI and Anthropic both launched dedicated clinical healthcare product lines this week, marking the moment frontier AI labs stop treating medicine as a downstream use case and start treating it as a strategic vertical with the FDA having cleared more than 1,000 AI clinical tools.
The Trump administration is actively promoting AI clinical tools to lower healthcare costs, but physician groups and hospital networks are resisting over unresolved liability and patient safety concerns.
Healthcare safety nonprofit ECRI ranked AI diagnostic technology as the number-one patient safety concern of 2026, citing over-reliance on AI tools trained on biased datasets and the absence of robust human oversight protocols.
The FDA has completed a sweeping data infrastructure overhaul, giving AI systems unified access to previously siloed datasets across divisions for faster drug and device reviews.
OpenAI released a healthcare policy blueprint calling for faster FDA pathways and expanded data access on the same day it launched ChatGPT for Clinicians — proposals critics say are designed to clear regulatory barriers for OpenAI's own commercial healthcare products.
The FDA launched Elsa 4.0 for all agency staff and consolidated more than 40 disparate data systems into a unified platform called HALO — putting the agency's entire data universe behind a single AI interface for the first time.